Prestige Wealth Management Group LLC Bio Rad Laboratories, Inc. Transaction History

Prestige Wealth Management Group LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 26, 2024	SELL	$359.49 - $486.4 $359 - $486	-1 Reduced 25.0%	3 $1,000
Q2 2023 Aug 11, 2023	SELL	$359.49 - $486.4 $359 - $486	-1 Reduced 25.0%	3 $1,000
Q1 2023 Apr 26, 2024	BUY	$418.69 - $503.0 $1,674 - $2,012	4 New	4 $1,000
Q1 2023 May 16, 2023	SELL	$418.69 - $503.0 $2,512 - $3,018	-6 Reduced 60.0%	4 $1,000
Q4 2022 Feb 07, 2023	BUY	$351.71 - $456.01 $3,165 - $4,104	9 Added 900.0%	10 $4,000
Q3 2022 Nov 01, 2022	BUY	$412.59 - $563.26 $412 - $563	1 New	1 $0
Q2 2022 Aug 10, 2022	SELL	$463.67 - $597.16 $9,273 - $11,943	-20 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$524.57 - $735.42 $3,147 - $4,412	-6 Reduced 23.08%	20 $11,000
Q2 2021 Aug 12, 2021	BUY	$576.64 - $649.04 $5,189 - $5,841	9 Added 52.94%	26 $17,000
Q1 2021 May 13, 2021	BUY	$547.01 - $662.35 $3,282 - $3,974	6 Added 54.55%	17 $9,000
Q4 2020 Feb 17, 2021	BUY	$510.68 - $643.45 $5,617 - $7,077	11 New	11 $6,000
Q1 2019 Aug 16, 2019	SELL	$224.3 - $317.41 $448 - $634	-2 Closed	0 $0
Q4 2018 Apr 16, 2019	BUY	$220.1 - $309.0 $440 - $618	2 New	2 $0

478

19.2M

15.7K

11.5K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.